Antitumor Effect of Bevacizumab in a Xenograft Model of Canine Hemangiopericytoma

Antitumor Effect of Bevacizumab in a Xenograft Model of Canine Hemangiopericytoma

Abstract.: Canine hemangiopericytoma (CHP) is characterized by frequent local recurrence and increased invasiveness. Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis in tumors. The aim of the present study was to investigate the effect of a single dose of bevacizumab on a...

Full description

Saved in:
Bibliographic Details
Main Authors: Masaki Michishita (Author), Tatsuya Uto (Author), Ryota Nakazawa (Author), Hisashi Yoshimura (Author), Kikumi Ogihara (Author), Yuko Naya (Author), Tsuyoshi Tajima (Author), Daigo Azakami (Author), Seigo Kishikawa (Author), Toshiro Arai (Author), Kimimasa Takahashi (Author)
Format: Book
Published: Elsevier, 2013-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items